The animal tissue assay utilizes nuclear scintillation detection to determine the enzymatic activity of glycogen synthase by measuring the incorporation of radio-labeled glucose into glycogen.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
The animal tissue assay utilizes nuclear scintillation detection to determine the enzymatic activity of glycogen synthase by measuring the incorporation of radio-labeled glucose into glycogen.
Glycogen is an important metabolite to many eukaryotic cells, integral to energy storage and quick energy release. The building of the molecule is dependent on glycogen synthase, a highly regulated enzyme with the primary function of facilitating the sequential attachment of glucose units in a growing glycogen polymer. This enzyme is allosterically activated by glucose-6-phosphate and inhibited at multiple sites by phosphorylation. Knowledge of glycogen synthase enzymatic activity is a key component of understanding glycogen metabolism, muscle energy levels, and metabolic disorders such as diabetes and glycogen storage diseases. Described here is a highly sensitive and effective method of determining the activity of glycogen synthase in animal muscle tissue by measuring the amount of integrated glucose, from radio-labeled [14C]-UDP-glucose, into glycogen molecules. This procedure utilizes radioactive 14C and will require the proper authorization and lab space for use and disposal. This procedure will also require access to a liquid scintillation counter.
Glycogen, a highly branched polysaccharide composed of glucose units, serves as an important energy reserve in various tissues, including muscles, liver, and brain1. Its synthesis and degradation are orchestrated by a complex system of specialized enzymes and regulatory proteins. Vital to its biosynthesis is the enzyme glycogen synthase (GYS), of which there are two isoforms (GYS1 and GYS2). GYS1 is a regulatory enzyme directly responsible for the creation of glycogen from glucose in non-liver cells, while GYS2 functions in the liver. This process, known as glycogenesis, is the sequential addition of an individual unit of glucose onto a growing glycogen chain. GYS catalyzes the transfer of glucose from the intermediate uridine diphosphate glucose (UDP-glucose) to the end of a glycogen chain, creating an alpha-1,4-glycosidic linkage2. In coordination with the glycogen branching enzyme, this reaction extends glycogen molecules, providing both efficient energy storage and release.
Assay techniques exist to measure the activity of the enzyme, with one of the more common groupings of methods consisting of those of the spectrophotometric variety3,4. These assays typically rely on a system of indirect coupled reactions and measure the absorbance of the downstream product, NADH, at 340 nm. One unit of NADH is consumed for every unit of UDP freed from UDP-glucose by glycogen synthase, producing a measurable excitation that directly correlates to glycogen synthase activity5,6. While spectrophotometry assays are relatively inexpensive and accessible, they come with the minor downside of relying on an indirect reaction and major downsides of interference by sample turbidity and lower sensitivity, especially an issue for smaller samples or samples with little/highly phosphorylated glycogen synthase. Fluorometric assays, using the coupled reactions described above, have been developed to improve sensitivity in muscle tissue from human7 and mouse8. Other techniques exist for quantifying glycogen synthase, such as immunoblotting9, and immunohistochemistry10; however, these techniques are only able to quantify the physical amount of enzyme and, at best, can infer activity from phosphorylation but not directly quantify enzyme activity11.
Among these enzyme assay techniques, radiochemical methods remain the most widely used for determining glycogen synthase activity in mammalian tissue due to their lack of interference by sample turbidity and their high sensitivity8,9. These assays incorporate radiolabeled glucose from UDP-glucose labeled with either 14C12 or 3H13 into glycogen, allowing for direct measurement of enzyme activity over a set amount of time. In the following procedure, a tissue sample containing glycogen synthase is exposed to UDP-glucose and glycogen primer. Glycogen synthase catalyzes the reaction shown in the equation below:
UDP-[14C]glucose + (glycogen)n → (glycogen)n+1[14C] + UDP
After a set amount of time, the reaction is terminated and the glycogen containing radiolabeled glucose is either precipitated onto filter paper12 (as described below) or subjected to gel filtration as described by Niederwanger et al.14 and measured using a scintillation detector. This method also includes a separate identical reaction that includes glucose-6-phosphate (G6P), an allosteric activator of glycogen synthase. Under conditions with sufficient levels of G6P, glycogen synthase activity is maximally activated, showcasing the absolute potential for glycogen synthase activity of a given sample. The method described here was modified from Suzuki and colleagues15 to a 96-well format and is optimized for use in mouse muscle tissue; however, the protocol can be altered for other tissues and animal species.
Despite the inherent cost and safety considerations associated with radioactive materials, radiochemical assays offer significant advantages over non-radioactive alternatives, provided instruments are available. The following procedure details a highly sensitive and robust means of determining the activity of glycogen synthase, a key enzyme in glycogen metabolism, in animal muscle tissue.
Access restricted. Please log in or start a trial to view this content.
All procedures were approved by the Ball State University Animal Care and Use Committee. Male and female cohorts of B6;129-Gaatm1Rabn/J wildtype mice, aged 3 months, are used as a representative example in this manuscript. The reagents and the equipment used are listed in the Table of Materials.
1. Preparation prior to assay
2. Radiochemical glycogen synthase activity reaction
CAUTION: This step contains the use of [14C]-UDP-glucose, which is a radioactive material. Handle, store, and dispose of in a manner approved by the Nuclear Regulatory Commission (NRC).
3. Measuring activity with scintillation detection
Access restricted. Please log in or start a trial to view this content.
Following the protocol, a printout created from the scintillation detector will contain the measured amount of ionizing radiation emitted from each chromatography paper containing vial, directly correlated to the activity level of glycogen synthase. The scintillation detector will compute the counts per minute (CPM) of detected radiation for each sample, blank, and total over a set amount of time. First convert CPM to DPM (disintegrations per min), which is based on the efficiency of the scintillation counter used (DPM=C...
Access restricted. Please log in or start a trial to view this content.
Measurement of glycogen synthase enzyme activity is a valuable tool for monitoring glycogen metabolism in various metabolic and disease states. Measurement in the absence and presence of glucose-6-phosphate (G6P) offers insight into the regulatory status of the enzyme and an indirect index of the phosphorylation state. [U-14C]-UDP-glucose incorporation assay is an efficient and well-documented technique for measuring glycogen synthase enzymatic activity, offering high sensitivity, substrate specificity, and ad...
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
Funding was provided in part by Ball State University, Indiana University School of Medicine-Muncie, and Aro Biotherapeutics.
Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| [14C] Uridine 5-diphospho-glucose | American Radiolabeled Chemicals | ARC 0154 | |
| 31 ETCHR chromatography paper | Whatman | 3031 915 | |
| Benzamidine hydrochloride hydrate | Sigma | B6506 | |
| Beta mercaptoethanol | Sigma | M3148 | |
| Dry bath | Torey Pines Scientific | SC25 | |
| Ethanol (200 proof) | PharmcoAaper | 111000200 | |
| Ethylene glycol tetraacetic acid (EGTA) | Sigma | E4378 | |
| Ethylenediaminetetraacetic acid (EDTA) | Sigma | E5134 | |
| Glucose-6-phosphate sodium salt | Sigma | G7879 | |
| Glycogen from rabbit liver (Type III) | Sigma | G8876 | |
| Microplate, flat-bottom, 96 well | Greiner | 655101 | |
| Microplate, pcr, 96 well | DOT Scientific | 951-PCR | |
| Multi-Purpose Scintillation Counter | Beckman Coulter | LS 6500 | |
| Potassium fluoride dihydrate | Sigma | 221872 | |
| Protease inhibitor cocktail | GoldBio | GB-108-2 | |
| Scintillation cocktail | Reasearch Products International | 111195 | |
| Scintillation vials | Reasearch Products International | 125509 | |
| Sodium fluoride | Sigma | S7920 | |
| Tissue Tearor | Biospec Products | Model 398 | |
| Tosyllysine Chloromethyl Ketone (TLCK) | Sigma | T7254 | |
| Trizma base (99.9%) | Sigma | T1503 | |
| Trizma hydrochloride | Sigma | T3253 | |
| Uridine 5-diphospo-glucose | Sigma | U-4625 |
Access restricted. Please log in or start a trial to view this content.